TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pro Medicus Limited ( (AU:PME) ) has shared an announcement.
Pro Medicus Limited held its Annual General Meeting on November 24, 2025, where all resolutions on the agenda were successfully carried. Key resolutions included the approval of the remuneration report and the re-election of board members, indicating strong shareholder support and stability in the company’s governance.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$350.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is a leader in the e-health and imaging industry, providing advanced healthcare solutions. The company focuses on delivering innovative imaging software and services to enhance medical diagnostics and patient care.
YTD Price Performance: 0.67%
Average Trading Volume: 170,664
Technical Sentiment Signal: Buy
Current Market Cap: A$26.27B
For an in-depth examination of PME stock, go to TipRanks’ Overview page.